Gut microbial metabolism defines host metabolism: an emerging perspective in obesity and allergic inflammation

Obesity Reviews

Volumn 18, Issue 1, 2017, Pages 18-31

  Kumari, M ^a   Kozyrskyj, A L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Gut; microbiota; overweight; short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; HISTONE DEACETYLASE; LACTIC ACID; MUCIN; PROPIONIC ACID; SEROTONIN; SHORT CHAIN FATTY ACID; VOLATILE FATTY ACID;

ALLERGIC ASTHMA; ALLERGY; BIOSYNTHESIS; CIRCADIAN RHYTHM; DECREASED APPETITE; DENDRITIC CELL; GLUCONEOGENESIS; HUMAN; INFLAMMATION; INTESTINE FLORA; LARGE INTESTINE; LIPID METABOLISM; METABOLITE; MICROBIAL METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; OBESITY; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; ASTHMA; BLOOD; HYPERSENSITIVITY; INFANT; MICROBIOLOGY;

ASTHMA; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERSENSITIVITY; INFANT; INFLAMMATION; INTESTINE, LARGE; OBESITY;

EID: 85003011821     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12484     Document Type: Review

References (118)

1. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 1998; 95: 6578–6583.
2. Blaut M. Ecology and physiology of the intestinal tract. Curr Top Microbiol Immunol 2013; 358: 247–272.
3. Koleva PT, Kim JS, Scott JA, Kozyrskyj AL. Microbial programming of health and disease starts during fetal life. Birth Defects Res C Embryo Today 2015; 105: 265–277.
4. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22: 250–253.
5. Kozyrskyj AL, Bahreinian S, Azad MB. Early life exposures: impact on asthma and allergic disease. Curr Opin Allergy Clin Immunol 2011; 11: 400–406.
6. Koleva PT, Bridgman SL, Kozyrskyj AL. The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients 2015; 7: 2237–2260.
7. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59–65.
8. Marchesi JR, Adams DH, Fava F et al. The gut microbiota and host health: a new clinical frontier. Gut 2016; 65: 330–339.
9. Nicholson JK, Holmes E, Kinross J et al. Host–gut microbiota metabolic interactions. Science 2012; 336: 1262–1267.
10. Simpson HL, Campbell BJ. Review article: dietary fibre–microbiota interactions. Aliment Pharmacol Ther 2015; 42: 158–179.
11. Gill SR, Pop M, Deboy RT et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355–1359.
12. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 6ra14.
13. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221–1227.
14. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG Jr. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78: 1500–1507.
15. van Best N, Hornef MW, Savelkoul PH, Penders J. On the origin of species: factors shaping the establishment of infant's gut microbiota. Birth Defects Res C Embryo Today 2015; 105: 240–251.
16. Rasmussen HS, Holtug K, Ynggard C, Mortensen PB. Faecal concentrations and production rates of short chain fatty acids in normal neonates. Acta Paediatr Scand 1988; 77: 365–368.
17. Martin FP, Moco S, Montoliu I et al. Impact of breast-feeding and high- and low-protein formula on the metabolism and growth of infants from overweight and obese mothers. Pediatr Res 2014; 75: 535–543.
18. Backhed F, Roswall J, Peng Y et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17: 852.
19. Bernal MJ, Periago MJ, Martinez R et al. Effects of infant cereals with different carbohydrate profiles on colonic function—randomised and double-blind clinical trial in infants aged between 6 and 12 months—pilot study. Eur J Pediatr 2013; 172: 1535–1542.
20. den Besten G, Lange K, Havinga R et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 2013; 305: G900–G910.
21. Frost G, Sleeth ML, Sahuri-Arisoylu M et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 2014; 5: 3611.
22. Holscher HD, Faust KL, Czerkies LA et al. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 2012; 36: 95S–105S.
23. Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013; 16: 246–254.
24. Ragsdale SW, Pierce E. Acetogenesis and the Wood–Ljungdahl pathway of CO(2) fixation. Biochim Biophys Acta 1784; 2008: 1873–1898.
25. Wolfe AJ. The acetate switch. Microbiol Mol Biol Rev 2005; 69: 12–50.
26. Bergstrom A, Skov TH, Bahl MI et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 2014; 80: 2889–2900.
27. Azad MB, Konya T, Maughan H et al. Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity. Allergy Asthma Clin Immunol 2013; 9: 15.
28. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002; 217: 133–139.
29. Scheppach W, Bartram P, Richter A et al. Effect of short-chain fatty acids on the human colonic mucosa in vitro. JPEN J Parenter Enteral Nutr 1992; 16: 43–48.
30. Donohoe DR, Garge N, Zhang X et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13: 517–526.
31. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 2004; 91: 915–923.
32. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004; 70: 5810–5817.
33. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014; 5: e00889.
34. Reichardt N, Duncan SH, Young P et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 2014; 8: 1323–1335.
35. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62: 67–72.
36. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004; 70: 7220–7228.
37. Hove H, Mortensen PB. Colonic lactate metabolism and D-lactic acidosis. Dig Dis Sci 1995; 40: 320–330.
38. Mayeur C, Gratadoux JJ, Bridonneau C et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One 2013; 8: e54335.
39. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17: 1519–1528.
40. Vernia P, Caprilli R, Latella G, Barbetti F, Magliocca FM, Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988; 95: 1564–1568.
41. Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S. Neurocardiac toxicity of racemic D, L-lactate fluids. Integr Physiol Behav Sci 1994; 29: 383–394.
42. Hesla HM, Stenius F, Jaderlund L et al. Impact of lifestyle on the gut microbiota of healthy infants and their mothers—the ALADDIN birth cohort. FEMS Microbiol Ecol 2014; 90: 791–801.
43. MacFarlane GT, Gibson GR. Co-utilization of polymerized carbon sources by Bacteroides ovatus grown in a two-stage continuous culture system. Appl Environ Microbiol 1991; 57: 1–6.
44. Sato T, Matsumoto K, Okumura T et al. Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model. FEMS Microbiol Ecol 2008; 66: 528–536.
45. Kanauchi O, Fujiyama Y, Mitsuyama K et al. Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int J Mol Med 1999; 3: 175–179.
46. Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr 2013; 110: 1253–1262.
47. Tsukahara T, Koyama H, Okada M, Ushida K. Stimulation of butyrate production by gluconic acid in batch culture of pig cecal digesta and identification of butyrate-producing bacteria. J Nutr 2002; 132: 2229–2234.
48. Belenguer A, Holtrop G, Duncan SH et al. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol Ecol 2011; 77: 107–119.
49. Hashizume K, Tsukahara T, Yamada K, Koyama H, Ushida K. Megasphaera elsdenii JCM1772T normalizes hyperlactate production in the large intestine of fructooligosaccharide-fed rats by stimulating butyrate production. J Nutr 2003; 133: 3187–3190.
50. Prabhu R, Altman E, Eiteman MA. Lactate and acrylate metabolism by Megasphaera elsdenii under batch and steady-state conditions. Appl Environ Microbiol 2012; 78: 8564–8570.
51. Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 2011; 6: 241–260.
52. Villanueva-Millan MJ, Perez-Matute P, Oteo JA. Gut microbiota: a key player in health and disease. A review focused on obesity. J Physiol Biochem 2015; 71: 509–525.
53. Ursell LK, Haiser HJ, Van Treuren W et al. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014; 146: 1470–1476.
54. Payne AN, Chassard C, Zimmermann M, Muller P, Stinca S, Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 2011; 1: e12.
55. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222–227.
56. Lin HV, Frassetto A, Kowalik EJ Jr et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012; 7: e35240.
57. Yamashita H, Fujisawa K, Ito E et al. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long–Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem 2007; 71: 1236–1243.
58. Gao Z, Yin J, Zhang J et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58: 1509–1517.
59. Arora T, Sharma R, Frost G. Propionate. Anti-obesity and satiety enhancing factor? Appetite 2011; 56: 511–515.
60. Chambers ES, Viardot A, Psichas A et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 2015; 64: 1744–1754.
61. Singh N, Gurav A, Sivaprakasam S et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40: 128–139.
62. Brown AJ, Goldsworthy SM, Barnes AA et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312–11319.
63. Le PE, Loison C, Struyf S et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278: 25481–25489.
64. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 2003; 303: 1047–1052.
65. Nohr MK, Pedersen MH, Gille A et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013; 154: 3552–3564.
66. Li G, Su H, Zhou Z, Yao W. Identification of the porcine G protein-coupled receptor 41 and 43 genes and their expression pattern in different tissues and development stages. PLoS One 2014; 9: e97342.
67. Xiong Y, Miyamoto N, Shibata K et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 2004; 101: 1045–1050.
68. Perry RJ, Peng L, Barry NA et al. Acetate mediates a microbiome–brain–beta-cell axis to promote metabolic syndrome. Nature 2016; 534: 213–217.
69. Tolhurst G, Heffron H, Lam YS et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364–371.
70. Psichas A, Sleeth ML, Murphy KG et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) 2015; 39: 424–429.
71. Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007; 98: 32–37.
72. Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013; 5: 178ra41.
73. De Vadder F, Kovatcheva-Datchary P, Goncalves D et al. Microbiota-generated metabolites promote metabolic benefits via gut–brain neural circuits. Cell 2014; 156: 84–96.
74. Delaere F, Duchampt A, Mounien L et al. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab 2012; 2: 47–53.
75. den Besten G, Bleeker A, Gerding A et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 2015; 64: 2398–2408.
76. Alex S, Lange K, Amolo T et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor gamma. Mol Cell Biol 2013; 33: 1303–1316.
77. Souza da Silva C, Haenen D, Koopmans SJ et al. Effects of resistant starch on behaviour, satiety-related hormones and metabolites in growing pigs. Animal 2014; 8: 1402–1411.
78. Reigstad CS, Salmonson CE, Rainey JF 3rd et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015; 29: 1395–1403.
79. Crane JD, Palanivel R, Mottillo EP et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat Med 2015; 21: 166–172.
80. Eckel-Mahan K, Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev 2013; 93: 107–135.
81. Montagner A, Korecka A, Polizzi A et al. Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals. Sci Rep 2016; 6: 20127.
82. Leone V, Gibbons SM, Martinez K et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 2015; 17: 681–689.
83. Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 1990; 70: 567–590.
84. Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TM, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 2014; 4: e121.
85. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–1031.
86. Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TM. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int J Obes (Lond) 2014; 38: 1525–1531.
87. Vogt JA, Wolever TM. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003; 133: 3145–3148.
88. Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond) 2015; 39: 1331–1338.
89. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259–1260.
90. Noverr MC, Huffnagle GB. The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy 2005; 35: 1511–1520.
91. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2015; 45: 43–53.
92. Maslowski KM, Vieira AT, Ng A et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282–1286.
93. Macia L, Tan J, Vieira AT et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 2015; 6: 6734.
94. Smith PM, Howitt MR, Panikov N et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–573.
95. Sandin A, Braback L, Norin E, Bjorksten B. Faecal short chain fatty acid pattern and allergy in early childhood. Acta Paediatr 2009; 98: 823–827.
96. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30: 1590–1596.
97. Arrieta MC, Stiemsma LT, Dimitriu PA et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015; 7: 307ra152.
98. Alduraywish SA, Standl M, Lodge CJ et al. Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies. Pediatr Allergy Immunol 2016. DOI: 10.1111/pai.12651.
99. Azad MB, Konya T, Guttman DS et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy 2015; 45: 632–643.
100. Tan J, McKenzie C, Vuillermin PJ et al. Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways. Cell Rep 2016; 15: 2809–2824.
101. Berni Canani R, Sangwan N, Stefka AT et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J 2016; 10: 742–750.
102. Tang ML, Ponsonby AL, Orsini F et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol 2015; 135: 737–744 e8.
103. Trompette A, Gollwitzer ES, Yadava K et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159–166.
104. Lambrecht BN, Hammad H. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 2012; 30: 243–270.
105. Thorburn AN, McKenzie CI, Shen S et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 2015; 6: 7320.
106. Balmer ML, Ma EH, Bantug GR et al. Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 2016; 44: 1312–1324.
107. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 2003; 52: 1442–1447.
108. Johansson ME, Gustafsson JK, Holmen-Larsson J et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014; 63: 281–291.
109. Jakobsson HE, Rodriguez-Pineiro AM, Schutte A et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep 2015; 16: 164–177.
110. Finnie IA, Dwarakanath AD, Taylor BA, Rhodes JM. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995; 36: 93–99.
111. Beyerlein A, von Kries R. Breastfeeding and body composition in children: will there ever be conclusive empirical evidence for a protective effect against overweight? Am J Clin Nutr 2011; 94: 1772S–1775S.
112. Victora CG, Bahl R, Barros AJ et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 2016; 387: 475–490.
113. Alm JS, Swartz J, Bjorksten B et al. An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol 2002; 13: 402–411.
114. Chow J, Panasevich MR, Alexander D et al. Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res 2014; 13: 2534–2542.
115. Azad MB, Konya T, Persaud RR et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 2016; 123: 983–993.
116. Smilowitz JT, O'Sullivan A, Barile D, German JB, Lonnerdal B, Slupsky CM. The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr 2013; 143: 1709–1718.
117. Marcobal A, Barboza M, Sonnenburg ED et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 2011; 10: 507–514.
118. Arrowsmith S, Kendrick A, Hanley JA, Noble K, Wray S. Myometrial physiology—time to translate? Exp Physiol 2014; 99: 495–502.